Vaccine News and Research

Latest Vaccine News and Research

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

A team of researchers measured the infectivity of SARS-CoV-2 variants C.1.2, Mu, and Delta+501S spike proteins and determined the susceptibility to neutralizing antibodies.

22 Oct 2021

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated people is reduced by 80% or more.

22 Oct 2021

Study shows immune profile heterogeneity amongst healthy adults

Researchers opted to use single-cell RNA-seq to observe single cells in detail as they encounter a specific antigen.

22 Oct 2021

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Scientists studied the efficacy of an intranasal booster composed of beta variant-spike protein S1 with IL-15 and TLR agonists in macaques that were previously immunized.

22 Oct 2021

Development of a safe and effective COVID-19 nanoparticle vaccine

Researchers from ReVacc scientific have attempted to demonstrate the effectiveness of a new vaccine, REVC-128, two weeks post-administration.

22 Oct 2021

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Researchers from Stanford University have been attempting to create a hydrogel-based vaccine delivery system that could improve the immune response's strength and duration.

22 Oct 2021

Study finds no link between COVID-19 vaccinations and risk of early miscarriages

A new study published in The New England Journal of Medicine has found no correlation between COVID-19 vaccinations and risk of first-trimester miscarriages, providing further evidence of the safety of COVID-19 vaccination during pregnancy.

22 Oct 2021

Boosting nonhuman primates with Moderna vaccine increases neutralizing antibody responses

Boosting nonhuman primates with the Moderna vaccine (mRNA-1273) six months after their primary vaccine series increased neutralizing activity against viral variants of concern, a new study shows.

22 Oct 2021

New AI-based tool helps clinicians understand and better predict adverse effects of COVID-19

The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.

22 Oct 2021

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.

22 Oct 2021

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

A recent study from the United Kingdom, published in the open-access journal Vaccines, implies that vaccinating adolescents and children may be pivotal in reducing infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as ensuing coronavirus disease (COVID-19) morbidity and mortality across all age groups.

21 Oct 2021

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

A nationwide advertising campaign launches today (Friday 22 October) as part of the government's call to the public to get their COVID-19 booster and flu jabs, to protect themselves and their loved ones this winter.

21 Oct 2021

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

In a recent study, researchers compared the efficacy of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines against infection SARS-CoV-2.

21 Oct 2021

U.S. life expectancy may drop for the second year, minorities most affected

Scientists estimate the effect of the pandemic on life expectancy at birth, at 65 years overall, as well as for individual populations.

21 Oct 2021

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

The National Institute of Allergy and Infectious Diseases has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

21 Oct 2021

Booster dose of COVID-19 vaccine significantly increases neutralizing antibodies in rhesus macaques

A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.

21 Oct 2021

KHN’s ‘What the Health?’: Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

21 Oct 2021

Vaccine News and Research

Latest Vaccine News and Research

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

Study shows immune profile heterogeneity amongst healthy adults

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Development of a safe and effective COVID-19 nanoparticle vaccine

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Study finds no link between COVID-19 vaccinations and risk of early miscarriages

Boosting nonhuman primates with Moderna vaccine increases neutralizing antibody responses

New AI-based tool helps clinicians understand and better predict adverse effects of COVID-19

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

U.S. life expectancy may drop for the second year, minorities most affected

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

Booster dose of COVID-19 vaccine significantly increases neutralizing antibodies in rhesus macaques

KHN’s ‘What the Health?’: Dems agree to agree, but not on what to agree on

Study: Covid-19 vaccine is over 90% effective at preventing deaths from Delta

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in